Scientists have identified rare plant chemicals in cannabis leaves for the first time, exposing hidden chemistry in a part of the plant often thrown away.

The finding accelerates the search for useful cannabis compounds beyond the chemicals that cause a high.

In leaf and flower samples from three commercial strains, the overlooked plant material carried signals that pointed to a more complicated chemical story.

Magriet Muller at Stellenbosch University (SU) documented compounds that had not previously been reported in cannabis.

The strongest surprise came from leaves. Rare flavoalkaloids live here, plant compounds that combine flavonoids and nitrogen-containing alkaloids.

Unexpectedly, these appeared mainly in one strain rather than across all three, to the surprise of the researchers.

That narrow pattern makes the discovery promising but constrained, posing a larger question of how much value may be hiding in cannabis waste.

Across the three strains, the team tentatively identified 79 compounds, including 16 flavoalkaloids in four related classes.

Several newly recorded chemicals belonged to flavonoids, common plant compounds tied to color and defense.

However, flavoalkaloids stood out because nature rarely generates them, making them uncommon.

“Most plants contain highly complex mixtures of phenolic compounds, and while flavonoids occur widely in the plant kingdom, the flavoalkaloids are very rare in nature,” Muller said.

Those rare molecules clustered mainly in the leaves of one strain, which made the finding harder to dismiss as background noise.

Leaf material gets less attention than cannabis flowers, yet the rarest signals came from leaves of one strain rather than across all samples.

Plant chemistry often changes by tissue. This is because leaves, flowers, roots, and stems face different threats and build different defenses.

For growers and scientists, that means the lower-value pile may not be chemically simple. Muller used two-dimensional liquid chromatography in the study.

This a sorting method that separates mixed chemicals twice – to pull apart compounds that would otherwise overlap.

The team paired that sorting with high-resolution mass spectrometry, which weighs fragments so precisely that formulas can be estimated.

Strong separation let the team pull rare flavoalkaloids away from the much more abundant flavonoids.

That approach matters because stronger common signals can hide rare ones, and create more unknowns.

One commercial strain carried the strongest leaf signal for flavoalkaloids, while the other two looked much more alike.

That uneven pattern matches a familiar problem in cannabis science. Plants can share a label style yet differ sharply inside their cells.

Selective breeding, hybrid ancestry, and growing conditions can all change the chemical mix by turning plant genes up or down.

Small sample size keeps the finding narrow, but the gap among just three strains makes the variation hard to ignore.

Medical promise does not mean medical proof, and this study did not test the newly detected compounds in people, animals, or cells.

Chemical fingerprints are not drug effects, so no one knows whether these leaf compounds fight inflammation, slow cancer, or help patients.

Still, the chemistry gives researchers targets to isolate and test before anyone treats rare signals as medical leads.

Cannabis research often centers on cannabinoids – chemicals that interact with the body’s signaling system.

They can alter mood, pain, appetite, or inflammation. Yet cannabis also makes other molecules that can shape smell, color, defense, and possible biological effects.

Earlier work on cannflavins, cannabis flavonoids that can affect inflammation pathways in lab models, showed how non-cannabinoid chemistry can carry medical interest.

The leaf discovery adds a rarer class to that wider picture without claiming that every compound will become useful.

Leaves are often treated as lower-priority material after harvest. The discovery of rare compounds changes the economic question from simple disposal to careful screening.

“Our analysis again highlights the medicinal potential of Cannabis plant material, currently regarded as waste,” said Professor André de Villiers at SU.

If future work confirms useful activity, growers could sort leaves by strain, chemistry, and purpose instead of treating them as stream of leftovers.

Quality controls would still matter, because a compound found in one strain cannot be assumed to appear in all cannabis plants.

Every major claim in the paper carries one important qualifier, the flavoalkaloids were tentatively identified.

That means the instruments matched likely formulas and patterns from broken-apart molecules, but scientists still need purified samples to confirm exact structures.

Some alkaloid groups – nitrogen-containing parts that can change biological behavior – could not be assigned from the available data.

Clear limits make the result more useful, not less, because they show exactly where the next experiments must begin.

The discovery reframes cannabis leaves as being worth testing, containing rare flavoalkaloids, strong strain differences, and overlooked phenolics.

Future work can map more strains, verify the structures, and test biological effects. But the current message is clear, waste material can still hold scientific value.

The study is published in the Journal of Chromatography A.

—–

Like what you read? Subscribe to our newsletter for engaging articles, exclusive content, and the latest updates.

Check us out on EarthSnap, a free app brought to you by Eric Ralls and Earth.com.

—–